Impact of SARS-CoV-2 infection and vaccination against COVID-19 on maternal and fetal immune outcomes – (The COVID & Pregnancy Study)

COVID-19

Determine how the maternal immune system reacts to COVID19 infection and Vaccination during pregnancy and their impacts on the neonatal immune system development. Our understanding of the mechanisms that govern pregnancy-associated changes in immune system function and the consequences of their disruption is incomplete due to a lack of studies following women throughout pregnancy in both healthy and at-risk pregnancies, especially during SARS- CoV2 infection and vaccination. It is imperative we address these questions by collecting samples from pregnant and postpartum lactating women with and without SARS-CoV-2 infection, assessing both systemic inflammation and virus specific immune responses, and correlating with immune phenotypes at the maternal-fetal interface and cord blood.

Eligibility:

  •  Pregnant women at least 18 years old
  • Are pregnant with 1 baby
  •  Gestational age greater or equal to 8 weeks
  • COVID 19 test positive OR Received a COVID19 vaccine

Compensation

You will receive $10 per blood draw, and $15 after the completion of all the surveys postpartum (3), for a maximum of $155 total reimbursement for your participation.

Whom do I contact for additional information:

To find out more information and to learn if you are qualified to participate, call the Pregnancy Research Group at 503-494-8748 or email us at mfmresearch@ohsu.edu.